WHO ICTRP trial
TREATMENT OF INTRAUTERINE GROWTH RESTRICTION WITH LOW MOLECULAR WEIGHT HEPARIN…
EUCTR2017-001905-33-ES · EU Clinical Trials Register · Authorised
Key facts
| Trial ID | EUCTR2017-001905-33-ES |
|---|---|
| Public title | TREATMENT OF INTRAUTERINE GROWTH RESTRICTION WITH LOW MOLECULAR WEIGHT HEPARIN: RANDOMIZED CLINICAL TRIAL (TRACIP STUDY) |
| Scientific title | TREATMENT OF INTRAUTERINE GROWTH RESTRICTION WITH LOW MOLECULAR WEIGHT HEPARIN: RANDOMIZED CLINICAL TRIAL (TRACIP STUDY) - TRACIP |
| Primary sponsor | Fundació Sant Joan de Déu |
| Registry | EU Clinical Trials Register |
| Recruitment status | Authorised |
| Study type | Interventional clinical trial of medicinal product |
| Phase | Human pharmacology (Phase I): no Therapeutic exploratory (Phase II): no Therapeutic confirmatory - (Phase III): yes Therapeutic use (Phase IV): no |
| Countries | Spain |
| Conditions | EARLY INTRAUTERINE GROWTH RESTRICTION MedDRA version: 20.0 Level: LLT Classification code 10048488 Term: Growth intrauterine retard System Organ Class: 100000114573 ;Therapeutic area: Diseases [C] - Female diseases of the urinary and… |
| Interventions | Trade Name: HIBOR 3.500 UI Product Name: LOW MOLECULAR WEIGHT HEPARIN Pharmaceutical Form: Injection INN or Proposed INN: heparin Other descriptive name: LOW MOLECULAR WEIGHT HEPARIN SODIUM Concentration unit: IU/ml international… |
| Registration date | Jul 31, 2017 |
| Target size | 50 |
| Secondary IDs | FSJD-TRACIP-2017 |
| Registry page | clinicaltrialsregister.eu |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: